Medical Care
Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Research Report 2025
- Sep 18, 25
- ID: 506384
- Pages: 74
- Figures: 72
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Non-Alcoholic Steatohepatitis (NASH) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Alcoholic Steatohepatitis (NASH) Treatment.
The Non-Alcoholic Steatohepatitis (NASH) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Alcoholic Steatohepatitis (NASH) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Alcoholic Steatohepatitis (NASH) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila
Segment by Type
Off-Label
Therapeutic
Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Alcoholic Steatohepatitis (NASH) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Non-Alcoholic Steatohepatitis (NASH) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Alcoholic Steatohepatitis (NASH) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Alcoholic Steatohepatitis (NASH) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila
Segment by Type
Off-Label
Therapeutic
Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Alcoholic Steatohepatitis (NASH) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Off-Label
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Perspective (2020-2031)
2.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Growth Trends by Region
2.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Dynamics
2.3.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Industry Trends
2.3.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
2.3.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
2.3.4 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue
3.1.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue (2020-2025)
3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue
3.4 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio
3.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2024
3.5 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment Head office and Area Served
3.6 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Product and Application
3.7 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Type
4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2026-2031)
5 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Application
5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
6.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
6.4 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
7.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
7.4 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
9.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
9.4 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Details
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.1.4 Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.1.5 Allergan Plc (Tobira) Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Details
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.3.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.3.5 Galmed Pharmaceuticals Recent Development
11.4 Genfit SA
11.4.1 Genfit SA Company Details
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.4.4 Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.4.5 Genfit SA Recent Development
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Details
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.5.4 Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.5.5 Gilead Sciences, Inc. Recent Development
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Details
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.7.4 Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.7.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Off-Label
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Perspective (2020-2031)
2.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Growth Trends by Region
2.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Dynamics
2.3.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Industry Trends
2.3.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
2.3.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
2.3.4 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue
3.1.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue (2020-2025)
3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue
3.4 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio
3.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2024
3.5 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment Head office and Area Served
3.6 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Product and Application
3.7 Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Type
4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2026-2031)
5 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Application
5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
6.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
6.4 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
7.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
7.4 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
9.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
9.4 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Details
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.1.4 Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.1.5 Allergan Plc (Tobira) Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Details
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.3.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.3.5 Galmed Pharmaceuticals Recent Development
11.4 Genfit SA
11.4.1 Genfit SA Company Details
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.4.4 Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.4.5 Genfit SA Recent Development
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Details
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.5.4 Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.5.5 Gilead Sciences, Inc. Recent Development
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Details
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
11.7.4 Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
11.7.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Off-Label
Table 3. Key Players of Therapeutic
Table 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2020-2025)
Table 8. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2026-2031)
Table 10. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Trends
Table 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
Table 12. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
Table 13. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
Table 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players (2020-2025)
Table 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2024)
Table 17. Ranking of Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Headquarters and Area Served
Table 20. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Product and Application
Table 21. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Allergan Plc (Tobira) Company Details
Table 47. Allergan Plc (Tobira) Business Overview
Table 48. Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 49. Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 50. Allergan Plc (Tobira) Recent Development
Table 51. Bristol Myers Squibb Company Details
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 54. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Galmed Pharmaceuticals Company Details
Table 57. Galmed Pharmaceuticals Business Overview
Table 58. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 59. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 60. Galmed Pharmaceuticals Recent Development
Table 61. Genfit SA Company Details
Table 62. Genfit SA Business Overview
Table 63. Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 64. Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 65. Genfit SA Recent Development
Table 66. Gilead Sciences, Inc. Company Details
Table 67. Gilead Sciences, Inc. Business Overview
Table 68. Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 69. Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 70. Gilead Sciences, Inc. Recent Development
Table 71. Intercept Pharmaceuticals, Inc. Company Details
Table 72. Intercept Pharmaceuticals, Inc. Business Overview
Table 73. Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 74. Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 75. Intercept Pharmaceuticals, Inc. Recent Development
Table 76. Zydus Cadila Company Details
Table 77. Zydus Cadila Business Overview
Table 78. Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 79. Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 80. Zydus Cadila Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis (NASH) Treatment Picture
Figure 2. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Off-Label Features
Figure 5. Therapeutic Features
Figure 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Online Provider Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Report Years Considered
Figure 12. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players in 2024
Figure 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2024
Figure 18. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 20. United States Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 24. Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2020-2031)
Figure 32. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Allergan Plc (Tobira) Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 49. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 50. Genfit SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 51. Gilead Sciences, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 52. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 53. Zydus Cadila Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Off-Label
Table 3. Key Players of Therapeutic
Table 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2020-2025)
Table 8. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2026-2031)
Table 10. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Trends
Table 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers
Table 12. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges
Table 13. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints
Table 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players (2020-2025)
Table 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2024)
Table 17. Ranking of Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Headquarters and Area Served
Table 20. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Product and Application
Table 21. Global Key Players of Non-Alcoholic Steatohepatitis (NASH) Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Allergan Plc (Tobira) Company Details
Table 47. Allergan Plc (Tobira) Business Overview
Table 48. Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 49. Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 50. Allergan Plc (Tobira) Recent Development
Table 51. Bristol Myers Squibb Company Details
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 54. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Galmed Pharmaceuticals Company Details
Table 57. Galmed Pharmaceuticals Business Overview
Table 58. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 59. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 60. Galmed Pharmaceuticals Recent Development
Table 61. Genfit SA Company Details
Table 62. Genfit SA Business Overview
Table 63. Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 64. Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 65. Genfit SA Recent Development
Table 66. Gilead Sciences, Inc. Company Details
Table 67. Gilead Sciences, Inc. Business Overview
Table 68. Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 69. Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 70. Gilead Sciences, Inc. Recent Development
Table 71. Intercept Pharmaceuticals, Inc. Company Details
Table 72. Intercept Pharmaceuticals, Inc. Business Overview
Table 73. Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 74. Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 75. Intercept Pharmaceuticals, Inc. Recent Development
Table 76. Zydus Cadila Company Details
Table 77. Zydus Cadila Business Overview
Table 78. Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Product
Table 79. Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025) & (US$ Million)
Table 80. Zydus Cadila Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis (NASH) Treatment Picture
Figure 2. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Off-Label Features
Figure 5. Therapeutic Features
Figure 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Online Provider Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Report Years Considered
Figure 12. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players in 2024
Figure 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2024
Figure 18. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 20. United States Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 24. Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2020-2031)
Figure 32. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Allergan Plc (Tobira) Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 49. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 50. Genfit SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 51. Gilead Sciences, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 52. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 53. Zydus Cadila Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232